Jim Cramer thinks Take-Two Interactive and Activision Blizzard have winning potential.
Jim Cramer ponders how nothing new can be great, and observes that a selloff can be quite embraceable.
Bristol-Myers has had a mostly negative narrative since October, TheStreet's Jim Cramer said.
Jim Cramer says oil demand is getting better and points to Schlumberger.
Halliburton reports earnings on Monday. Investors bailing on energy stocks might regret that decision, Cramer said.
Jim Cramer doesn't like retail and he doesn't like health care stocks. Here's why.
Jim Cramer looks at Bristol-Myers Squibb's Opdivo setback.